Home
Conditions
Anemia, Hemolytic, Autoimmune

Clinical trial condition

Anemia, Hemolytic, Autoimmune

Explore clinical trials studying Anemia, Hemolytic, Autoimmune. Study availability and eligibility vary by location and protocol.

69 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Anemia, Hemolytic, Autoimmune trial results

Completed

Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease

NCT01696474

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations: Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria Foggia, Italy

Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milan, Italy

Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy

U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy

View Trial Details

Completed

Therapy of Chronic Cold Agglutinin Disease With Eculizumab

NCT01303952

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +8 more
Locations: Department of Hematology, University Hospital Essen Essen, Germany

View Trial Details

Completed

Treatment of Autoimmune Thrombocytopenia (AITP)

NCT00001630

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +10 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease

NCT02689986

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +9 more
Locations: Herlev University Hospital Copenhagen, Denmark

Turku University Hospital Turku, Finland

Haukeland University Hospital Bergen, Norway

Vestre Viken Hospital Drammen, Norway

View Trial Details

Completed

Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia

NCT01134432

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +4 more
Locations: Aalborg Hospital Aalborg, Denmark

Rigshospitalet - Copenhagen University Hospital Copenhagen, Denmark

Esbjerg Sygehus Esbjerg, Denmark

Haderslev Sygehus Haderslev, Denmark

View Trial Details

Completed

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

NCT00960713

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: Service de médecine interne, hôpital Purpan, place du Dr Baylac Toulouse, France

View Trial Details

Completed

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

NCT00749112

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +20 more
Locations: Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitario contra el Cancer Monterrey, Nuevo León, Mexico

View Trial Details

Completed

Therapy for Chronic Cold Agglutinin Disease

NCT00373594

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +11 more
Locations: Haukeland University Hospital Bergen, Norway

Haugesund Hospital Haugesund, Norway

Ullevaal University Hospital Oslo, Norway

Rikshospitalet-Radiumhospitalet University Hospital Oslo, Norway

View Trial Details

Completed

Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease

NCT00010387

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +28 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Anemia, Hemolytic, Autoimmune

Anemia, Hemolytic, Autoimmune trial results

Related conditions